FDA Warns Home Infusion Company

Drug Industry Daily
A A
The FDA cited an Illinois provider of home infusion therapy for failing to meet sterile production standards, according to a warning letter from the agency.

To View This Article:

Login

Subscribe To Drug Industry Daily